OPTIMUM INVESTMENT ADVISORS – Bristol-Myers Squibb Company Transaction History
OPTIMUM INVESTMENT ADVISORS portfolio value:
$1.57M
portfolio value
OPTIMUM INVESTMENT ADVISORS quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.76% | -169 shares | -144K | $71.09 | 22.10K |
| Q2 2022 | share | Decrease | -4.26% | -990 shares | 16K | $77 | 22.27K |
| Q1 2022 | share | Decrease | -1.69% | -400 shares | 224K | $73.03 | 23.26K |
| Q4 2021 | share | Decrease | -9.18% | -2.39K shares | -67K | $62.52 | 23.66K |
| Q3 2021 | share | Decrease | -31.03% | -11.72K shares | -982K | $59.17 | 26.05K |
| Q2 2021 | share | Decrease | -8.45% | -3.48K shares | -81K | $65.79 | 37.77K |
| Q1 2021 | share | Decrease | -3.73% | -1.6K shares | -54K | $62.15 | 41.26K |
| Q4 2020 | share | Decrease | -3.81% | -1.7K shares | -28K | $60.6 | 42.86K |
| Q3 2020 | share | Decrease | -11.38% | -5.72K shares | -270K | $58 | 44.56K |
| Q2 2020 | share | Increase | +0.80% | 400 shares | 176K | $56.14 | 50.29K |
| Q1 2020 | share | Decrease | -4.99% | -2.61K shares | -590K | $52.79 | 49.89K |
| Q4 2019 | share | Increase | +5.90% | 2.92K shares | 857K | $60.36 | 52.50K |
| Q3 2019 | share | Increase | +2.59% | 1.25K shares | 322K | $47.3 | 49.58K |
| Q2 2019 | share | Decrease | -6.78% | -3.51K shares | -282K | $41.93 | 48.33K |
| Q1 2019 | share | Decrease | -2.99% | -1.6K shares | -304K | $43.73 | 51.84K |
| Q4 2018 | share | Decrease | -2.78% | -1.53K shares | -635K | $47.21 | 53.44K |
| Q3 2018 | share | Decrease | -0.68% | -375 shares | 350K | $56.02 | 54.97K |
| Q2 2018 | share | Decrease | -2.90% | -1.65K shares | -543K | $49.59 | 55.35K |
| Q1 2018 | share | Decrease | -0.18% | -100 shares | 106K | $56.31 | 57.00K |
| Q4 2017 | share | Decrease | -1.31% | -760 shares | -189K | $54.21 | 57.10K |
| Q3 2017 | share | Increase | +1.31% | 750 shares | 506K | $56.04 | 57.86K |
| Q2 2017 | share | Decrease | -2.64% | -1.55K shares | -7K | $48.65 | 57.11K |
| Q1 2017 | share | Decrease | -2.25% | -1.35K shares | -318K | $47.14 | 58.66K |
| Q4 2016 | share | Decrease | -1.77% | -1.08K shares | 214K | $50.32 | 60.01K |
| Q3 2016 | share | Decrease | -4.12% | -2.62K shares | -1.39M | $46.11 | 61.09K |
| Q2 2016 | share | Decrease | -5.34% | -3.59K shares | 387K | $62.9 | 63.72K |
| Q1 2016 | share | Decrease | -3.19% | -2.22K shares | -484K | $54.35 | 67.31K |